GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
93 hedge funds and large institutions have $457M invested in G1 Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 17 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
13% less capital invested
Capital invested by funds: $525M → $457M (-$68.8M)
Holders
93
Holding in Top 10
–
Calls
$183K
Puts
$178K
Top Buyers
| 1 | +$14.4M | |
| 2 | +$6.03M | |
| 3 | +$4M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.19M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.93M |
Top Sellers
| 1 | -$19M | |
| 2 | -$18.6M | |
| 3 | -$5.01M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.47M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$2.58M |